Literature DB >> 29486589

Autophagy Attenuates Angiotensin II-Induced Pulmonary Fibrosis by Inhibiting Redox Imbalance-Mediated NOD-Like Receptor Family Pyrin Domain Containing 3 Inflammasome Activation.

Ying Meng1, Miaoxia Pan1, Bojun Zheng1, Yan Chen2, Wei Li3, Qianjie Yang1, Zemao Zheng1, Nana Sun1, Yue Zhang1, Xu Li4,5.   

Abstract

AIMS: The NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome, which is activated by reactive oxygen species (ROS) and repressed by autophagy, has been identified as a novel agent of pulmonary fibrosis. Angiotensin II (AngII), the bioactive pro-oxidant in the renin-angiotensin system, aggravates lung fibrosis. However, the effect of AngII on NLRP3 inflammasome and autophagy in lung fibrosis remains unknown. This study investigates the potential link between AngII-induced autophagy in the regulation of NLRP3 inflammasome/IL-1β axis in lung fibrosis.
RESULTS: In vivo, autophagy and the NLRP3 inflammasome were activated in fibrotic patients and positively correlated with oxidation. Treatment with rapamycin promoted autophagy but inhibited oxidation, NLRP3 inflammasome, and lung fibrosis after bleomycin (BLM) infusion. The autophagy inhibitor 3-methyladenine reduced BLM-induced lung fibrosis and concurrently facilitated NLRP3 inflammasome activation and oxidation in fibroblasts. In vitro, AngII promoted intercellular ROS, hydrogen peroxide, and NADPH oxidase 4 (NOX4) protein levels and reduced the glutathione concentration, thereby leading to NLRP3 inflammasome activation and consequent collagen synthesis. AngII induced autophagy, while VAS2870, NOX4, small-interfering RNA (siRNA), and compound C eliminated AngII-induced LC3B augmentation. Moreover, blocking autophagy with bafilomycin A1 or LC3B siRNA resulted in oxidant accumulation, NLRP3 inflammasome hyperactivation, and collagen deposition. Finally, AngII induced P62/SQSTM1, targeting ubiquitinated apoptosis-associated speck-like protein containing a CARD for degradation, thereby contributing to NLRP3 inflammasome inactivation. Innovation and
Conclusion: Autophagy attenuates pulmonary fibrosis by regulating NLRP3 inflammasome activation induced by AngII-mediated ROS via redox balance modulation.

Entities:  

Keywords:  NADPH oxidase 4; NLRP3 inflammasome; P62/SQSTM1; angiotensin II; autophagy; lung fibrosis; mitochondria; nuclear erythroid 2-related factor 2

Mesh:

Substances:

Year:  2018        PMID: 29486589     DOI: 10.1089/ars.2017.7261

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  23 in total

1.  Dimethylaminomicheliolide ameliorates peritoneal fibrosis through the activation of autophagy.

Authors:  Shuting Li; Fenfen Peng; Wangqiu Gong; Jiayu Wu; Yuxian Wang; Zhaozhong Xu; Wenting Liu; Hongyu Li; Bohui Yin; Ying Zhang; Sijia Chen; Congwei Luo; Peilin Li; Yihua Chen; Qianyin Huang; Weidong Zhou; Haibo Long
Journal:  J Mol Med (Berl)       Date:  2019-03-11       Impact factor: 4.599

Review 2.  Mechanisms for the Resolution of Organ Fibrosis.

Authors:  Jeffrey C Horowitz; Victor J Thannickal
Journal:  Physiology (Bethesda)       Date:  2019-01-01

3.  Autophagy in pulmonary fibrosis: friend or foe?

Authors:  Charlotte Hill; Yihua Wang
Journal:  Genes Dis       Date:  2022-11

4.  Autophagy Activation Improves Lung Injury and Inflammation in Sepsis.

Authors:  Hongying Zhao; Hongguang Chen; Meng Xiaoyin; Guotao Yang; Ying Hu; Keliang Xie; Yonghao Yu
Journal:  Inflammation       Date:  2019-04       Impact factor: 4.092

Review 5.  Self-eating: friend or foe? The emerging role of autophagy in fibrotic diseases.

Authors:  Yajing Li; Runping Liu; Jianzhi Wu; Xiaojiaoyang Li
Journal:  Theranostics       Date:  2020-06-29       Impact factor: 11.556

Review 6.  Targeting NLRP3 Inflammasome in the Treatment of CNS Diseases.

Authors:  Bo-Zong Shao; Qi Cao; Chong Liu
Journal:  Front Mol Neurosci       Date:  2018-09-04       Impact factor: 5.639

Review 7.  Obesity-Related Inflammation and Endothelial Dysfunction in COVID-19: Impact on Disease Severity.

Authors:  Andrea De Lorenzo; Vanessa Estato; Hugo C Castro-Faria-Neto; Eduardo Tibirica
Journal:  J Inflamm Res       Date:  2021-05-27

Review 8.  RAAS, ACE2 and COVID-19; a mechanistic review.

Authors:  Ahmed Elshafei; Emad Gamil Khidr; Ahmed A El-Husseiny; Maher H Gomaa
Journal:  Saudi J Biol Sci       Date:  2021-07-10       Impact factor: 4.219

9.  SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45- Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome.

Authors:  Mariusz Z Ratajczak; Kamila Bujko; Andrzej Ciechanowicz; Kasia Sielatycka; Monika Cymer; Wojciech Marlicz; Magda Kucia
Journal:  Stem Cell Rev Rep       Date:  2021-02       Impact factor: 5.739

10.  Hyperoxia reduces STX17 expression and inhibits the autophagic flux in alveolar type II epithelial cells in newborn rats.

Authors:  Dan Zhang; Xinyi Zhao; Dingning Zhang; Siyang Gao; Xindong Xue; Jianhua Fu
Journal:  Int J Mol Med       Date:  2020-05-27       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.